Jinping Lai

Title: Innovations of Jinping Lai in Drug Delivery Systems

Introduction

Jinping Lai is an accomplished inventor based in Highland Park, NJ (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that enhances real-time monitoring of drug release.

Latest Patents

Jinping Lai holds a patent for "FRET-based mesoporous silica nanoparticles for real-time monitoring of drug release." This invention involves a compound that includes a drug carrier made of coumarin-labeled-cysteine tethered mesoporous silica nanoparticles (MSNs) loaded with a pharmaceutically active agent. Additionally, it features a fluorescein isothiocyanate-β-cyclodextrin (FITC-β-CD) that is covalently linked to the cysteine, which blocks the release of the active agent. The unique mechanism allows for the cleavage of the covalent linkage, resulting in the removal of the cyclodextrin and the release of the pharmaceutically active agent. The drug carrier exhibits different emission wavelengths based on the integrity of the covalent linkage, providing a reliable method for monitoring drug release.

Career Highlights

Jinping Lai is affiliated with Rutgers, The State University of New Jersey, where he continues to advance research in drug delivery technologies. His work has garnered attention for its potential applications in improving therapeutic outcomes.

Collaborations

Jinping Lai collaborates with notable colleagues, including Ki-Bum Lee and Birju Shah, who contribute to his research endeavors and innovations in the field.

Conclusion

Jinping Lai's innovative work in drug delivery systems exemplifies the importance of advancements in medical technology. His patent on FRET-based mesoporous silica nanoparticles represents a significant step forward in real-time drug monitoring, showcasing his commitment to improving healthcare solutions.